Patents by Inventor Jitendra Ramanlal Dave

Jitendra Ramanlal Dave has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury
    Patent number: 10041959
    Abstract: Processes and materials are provided for the detection, diagnosis, or determination of the severity of a neurological injury or condition, including traumatic brain injury, multiple-organ injury, stroke, Alzeimer's disease, Parkinson disease and Chronic Traumatic Encephalopathy (CTE). The processes and materials include biomarkers detected or measured in a biological sample such as whole blood, serum, plasma, or CSF. Such biomarkers include Tau and GFAP proteins, their proteolytic breakdown products, brain specific or enriched micro-RNA, and brain specific or enriched protein directed autoantibodies. The processes and materials are operable to detect the presence of absence of acute, subacute or chronic brain injuries and predict outcome for the brain injury.
    Type: Grant
    Filed: December 27, 2016
    Date of Patent: August 7, 2018
    Assignees: Banyan Biomarkers, Inc., The United States of America, as Represented by the Secretary of the Army
    Inventors: Kevin Ka-Wang Wang, Zhiqun Zhang, Ming-Cheng Liu, Ronald L. Hayes, Jitendra Ramanlal Dave
  • MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY
    Publication number: 20170242041
    Abstract: Processes and materials are provided for the detection, diagnosis, or determination of the severity of a neurological injury or condition, including traumatic brain injury, multiple-organ injury, stroke, Alzeimer's disease, Parkinson disease and Chronic Traumatic Encephalopathy (CTE). The processes and materials include biomarkers detected or measured in a biological sample such as whole blood, serum, plasma, or CSF. Such biomarkers include Tau and GFAP proteins, their proteolytic breakdown products, brain specific or enriched micro-RNA, and brain specific or enriched protein directed autoantibodies. The processes and materials are operable to detect the presence of absence of acute, subacute or chronic brain injuries and predict outcome for the brain injury.
    Type: Application
    Filed: December 27, 2016
    Publication date: August 24, 2017
    Applicant: BANYAN BIOMARKERS, INC.
    Inventors: Kevin Ka-Wang WANG, Zhiqun ZHANG, Ming-Cheng LIU, Ronald L. HAYES, Jitendra Ramanlal DAVE
  • ENDOTHELIAL-MONOCYTE ACTIVATING POLYPEPTIDE II (EMAP-II), A BIOMARKER FOR USE IN DIAGNOSIS AND TREATMENT OF BRAIN INJURY
    Publication number: 20150057193
    Abstract: A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP II) and comparing to a control. An increase of EMAP II indicates the presence of traumatic brain injury and a decrease of EMAP II indicates the presence of ischemic brain injury.
    Type: Application
    Filed: September 26, 2014
    Publication date: February 26, 2015
    Inventors: JITENDRA RAMANLAL DAVE, CHANGPING YAO, ANTHONY JOSEPH WILLIAMS, XI-CHUN MAY-LU, FRANK CASPER TORTELLA, KA-WANG KEVIN WAND, RONALD LAWRENCE HAYES
  • Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury
    Publication number: 20110028349
    Abstract: A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury.
    Type: Application
    Filed: August 19, 2010
    Publication date: February 3, 2011
    Inventors: Jitendra Ramanlal Dave, Changping Yao, Anthony Joseph Williams, Xi-Chun May, Frank Casper Tortella, Ka-Wang Kevin Wang, Ronald Lawrence Hayes
  • Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis of brain injury
    Patent number: 7799536
    Abstract: A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury. Detection of EMAP-II can be done in brain tissue, biofluids such as cerebrospinal fluid or blood (including plasma and serum).
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: September 21, 2010
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Jitendra Ramanlal Dave, Changping Yao, Anthony Joseph Williams, Xi-Chun May, Frank Casper Tortella, Ka-Wang Kevin Wang, Ronald Lawrence Hayes
  • Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis and treatment of brain injury
    Publication number: 20090068691
    Abstract: A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury.
    Type: Application
    Filed: October 28, 2008
    Publication date: March 12, 2009
    Inventors: Jitendra Ramanlal Dave, Changping Yao, Anthony Joseph Williams, Xi-Chun May, Frank Casper Tortella, Ka-Wang Kevin Wang, Ronald Lawrence Hayes